[Effect of dithranol therapy on membrane, basement membrane and nuclear markers in psoriasis lesions].
We investigated the effects of anti-psoriatic therapy with dithranol (1/20-1%) in salicylic acid (0.5%) in white petrolatum on lesional skin. FITC-labeled lectins and pemphigus vulgaris antibodies (PV) served as analytical means to study the glycocalyx. Antibodies of bullous pemphigoid (BP) were used as basal membrane markers. Nuclear antigens were recorded according to the binding of speckled, anti-nuclear antibodies (ANA) as well as antibodies to dsDNA. With some lectins, dithranol therapy resulted in pronounced fluorescence of the lower parts of the basal cells. ConA was fixed by the basal cell layer. To a lesser degree, ANA were fixed by nuclei of keratinocytes. PV antibodies were not fixed at all.
D000328:Adult; D000875:Anthralin / Q000627:therapeutic use*; D000974:Antibodies, Antinuclear / Q000032:analysis*; D001485:Basement Membrane / Q000187:drug effects* / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011134:Polysaccharides / Q000378:metabolism*; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology
D000974:Antibodies, Antinuclear; D006023:Glycoproteins; D011134:Polysaccharides; D000875:Anthralin
Einfluss der Dithranoltherapie auf Membran-, Basal-membran- und Kernmarker in der Psoriasisläsion.